BCS Private Wealth Management Inc. Purchases New Holdings in HCA Healthcare, Inc. $HCA

BCS Private Wealth Management Inc. bought a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 1,127 shares of the company’s stock, valued at approximately $432,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of HCA. Chung Wu Investment Group LLC bought a new position in shares of HCA Healthcare during the 2nd quarter worth approximately $27,000. Clearstead Trust LLC lifted its stake in shares of HCA Healthcare by 311.8% during the 2nd quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after buying an additional 53 shares during the last quarter. Ameriflex Group Inc. bought a new position in HCA Healthcare in the 2nd quarter valued at about $27,000. Saudi Central Bank acquired a new position in shares of HCA Healthcare in the first quarter valued at approximately $26,000. Finally, WPG Advisers LLC bought a new stake in HCA Healthcare in the 1st quarter valued at $27,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA opened at $488.44 on Wednesday. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $520.00. The stock has a fifty day moving average of $462.50 and a 200-day moving average of $411.98. The stock has a market capitalization of $111.46 billion, a price-to-earnings ratio of 18.88, a PEG ratio of 1.43 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. During the same period last year, the firm posted $4.90 earnings per share. The business’s revenue for the quarter was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s payout ratio is 11.13%.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on HCA shares. The Goldman Sachs Group raised their price target on shares of HCA Healthcare from $470.00 to $520.00 and gave the stock a “buy” rating in a research report on Monday, October 27th. Zacks Research lowered HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 27th. UBS Group raised their price target on HCA Healthcare from $495.00 to $525.00 and gave the stock a “buy” rating in a research report on Monday, October 27th. Stephens upped their price target on shares of HCA Healthcare from $450.00 to $500.00 and gave the stock an “overweight” rating in a report on Monday, October 27th. Finally, Wells Fargo & Company upped their target price on HCA Healthcare from $412.00 to $431.00 and gave the stock an “equal weight” rating in a research note on Thursday, November 13th. Fourteen equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $474.53.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the sale, the executive vice president owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. This represents a 52.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.